Datalogic supports the French Foundation for Rare Diseases

Paris – February, 20th 2015 – Datalogic, a global leader in the Automatic Data Capture and Industrial Automation markets and world-class producer of bar code readers, mobile computers, sensors, vision systems and laser marking equipment, is proud to support the French Foundation for rare diseases.

Today, 3 million people in France, 30 million people in Europe, 300 million worldwide (i.e. 6-8% of the world’s population), of which half are children, are now affected by one of the 7,000 rare diseases! Rare diseases are far from being exceptional, they are a major public health challenge. However, for these 7,000 rare diseases only 200 treatments are available. 

Created in February 2012, the French Foundation for rare diseases aims to coordinate, rise funds and support research teams for the development of new treatments for all rare diseases. As a private non-profit organization, the Foundation actively participate to the 2nd National Plan on Rare Diseases 2011 - 2014. It was created with the support of 5 founding members: AFM-Téléthon, the Alliance Maladies Rares, Inserm, the Conference of French Universities Presidents and the French University Hospitals CEO.

Since its creation, the Foundation has deployed a team of professionals across France to help understanding rare diseases, developing new treatments and improving the patient quality of life. The Foundation is also active in Europe and internationally, as a partner of several collaborative programs.

As a company socially responsible, Datalogic has always dedicated a particular and constant attention to health and safety of its workers as well as of the community where it operates.

Ethic and sense of commitment have always been crucial for Datalogic and its employees. By supporting the French Foundation for rare diseases, we are proud to give our time and resources to help serving the public interest.” Stated Guillaume Vicot, Vice President West Europe and Africa at Datalogic ADC. “Our partnership with the French foundation for rare disease is part of a long term approach,  therefore, we will extend our activities along with the foundation in 2015” he added.